COFCO Biotechnology announces new executives, organizational adjustments

COFCO Biotechnology convened its 9th Board of Directors' 11th extraordinary meeting on December 12, 2025, approving several significant changes. The board passed resolutions to appoint Ms. Jiang Jingru as a securities affairs representative, effective until the current board's term expires. This increases the company's securities affairs representatives to two, working alongside Mr. Zhang Qitong.

Additionally, the board approved the appointment of Mr. Zhang Bao as deputy general manager, with his term extending until the conclusion of the 9th managerial term. Mr. Zhang Bao, born in February 1971, holds a university degree and an engineering master's, with extensive experience in financial management and leadership roles within the COFCO Group. These personnel changes are part of a broader organizational restructuring aimed at enhancing data governance, industrial capabilities, and the modernization of the company's industrial chain.

The new organizational structure optimizes internal management without significantly impacting production and operations. The company assures that all appointees meet the necessary qualifications and legal requirements.